Serum Lipolytic Activity in Cancer Patients
Author Information
Author(s): S.A. Beck, P. Groundwater, C. Barton, M.J. Tisdale
Primary Institution: Cancer Research Campaign Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University
Hypothesis
The study investigates the effect of chemotherapy on serum lipid mobilizing activity in cancer patients with varying degrees of weight loss.
Conclusion
Cancer patients have higher serum lipolytic activity compared to normal controls, and this activity decreases in patients who respond to chemotherapy.
Supporting Evidence
- Cancer patients have higher serum lipolytic activity than normal controls.
- Patients who responded to chemotherapy showed a decrease in serum lipolytic activity.
- The correlation coefficient for serum lipolytic activity and weight loss was 0.81 for small weight losses.
Takeaway
Cancer patients have more fat in their blood, and this can change when they get treatment. If they get better, the fat levels go down.
Methodology
The study involved 13 cancer patients whose serum lipolytic activity was measured before, during, and after treatment using chromatographic techniques.
Potential Biases
Potential drug interference in the bioassay could affect results.
Limitations
The study's findings need confirmation in a larger group of patients and using more specific methods.
Participant Demographics
13 patients (7 male, 6 female) with histologically proven malignancy and varying degrees of weight loss.
Statistical Information
P-Value
p<0.001 for comparison with Alzheimer's patients, p<0.05 for pre- and post-treatment comparison.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website